The offer and sale of the Shares, if any, will be made pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-296301), including the base prospectus contained therein, which was initially filed with the United States Securities and Exchange Commission (the "Commission") on May 28, 2026, and was declared effective, as amended, by the Commission on June 26, 2026 and as supplemented by the prospectus supplement, dated September 10, 2026, filed with the Commission pursuant to Rule 424(b)(5) of the Securities Act of 1933, as amended (the "Securities Act"), relating to the Shares which may be issued from time to time pursuant to the Sales Agreement, (the "Prospectus Supplement"). Pursuant to the Prospectus Supplement, the Company may offer and sell up to U.S.$200,000,000 of Shares.

Under the Sales Agreement, subject to the terms of the placement notice defined in the Sales Agreement, the Agent may sell Placement Shares by any method permitted by law deemed to be an "at-the-market offering" as defined in Rule 415 under the Securities Act.